NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

OpenAI CEO Sam Altman Denies Betraying Nonprofit's Mission, Says Elon Musk Wanted Control and Profit

OpenAI Chief Executive Sam Altman has rejected Elon Musk's claim that he betrayed the ChatGPT maker's founding mission to serve the public good. Instead, Altman alleged that Musk was interested in seizing control of OpenAI and making money from it.

The dispute arises from a lawsuit filed by Musk in August 2024, in which he accused Altman and OpenAI of persuading him into giving $38 million, only to see the nonprofit abandon its mission to benefit humanity and instead become a for-profit corporation. The trial, now in its third week, may determine the future of OpenAI and its leadership, as it prepares for a possible initial public offering that could value the business at $1 trillion.

Under questioning from his lawyer in the Oakland, California, federal court, Altman denied Musk's contention that he and OpenAI President Greg Brockman, who is also a defendant, tried to "steal a charity." Altman stated that he hoped OpenAI's continued success would benefit the nonprofit, which has raised $175 billion from private investors across its lifetime.

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

Musk, the world's richest person, is seeking about $150 billion in damages from OpenAI and Microsoft, a major investor, to be paid to an OpenAI nonprofit. He also wants Altman and Brockman removed from their roles.

Comparison of OpenAI's Funding

SourceFunding Amount
Private Investors$175 billion
Microsoft(amount not specified)

The trial marks a clash among tech giants, with Musk portraying himself as a defender of ordinary people from the perils of artificial intelligence and Silicon Valley titans who care more about money. Musk testified early in the trial that "if you have someone who is not trustworthy in charge of AI, I think that’s a very big danger for the whole world."

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

Altman, on the other hand, said that Musk once demanded a 90% stake in OpenAI and was "extremely uncomfortable" with ceding majority control. He also recalled that Musk wanted a merger with Tesla, Musk's electric car company, but Altman balked at the proposal, citing concerns that Tesla's mission would be compromised.

Musk's lawyer, Steven Molo, challenged Altman's honesty during a contentious cross-examination, citing testimony from a former OpenAI board member that Altman fostered a "toxic culture of lying" and from seven former OpenAI officials who said Altman wasn't trustworthy. Altman responded that he is an honest and trustworthy business person, but acknowledged that he had considered not returning to OpenAI after being ousted by its board in 2023.

The trial comes after OpenAI raised hundreds of billions of dollars from large technology companies and investors to add computing power. OpenAI's chairman, Bret Taylor, testified separately on Tuesday that OpenAI received a formal takeover offer from a consortium led by Musk's rival company xAI in February 2025, six months after Musk sued.

Testimony may conclude this week, and jurors could begin deliberating whether the defendants are liable by May 18. U.S. District Judge Yvonne Gonzalez Rogers, who oversees the trial, would determine any remedies.

Investor Takeaway

OpenAI's leadership and business model are under scrutiny, which may impact its future and potential IPO.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.